-
2023-503640-14-00
5
2022-02-17
Newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphobla
-
2023-508248-23-00
5
2021-11-26
Non-alcoholic steatohepatitis (NASH)
-
2023-507698-16-00
5
2021-10-14
Chronic Lymphocytic Leukemia/Small
Lymphocytic Lymphoma (BRUIN CLL-322
-
2023-506270-13-00
4
2021-07-27
Relapsed/refractory diffuse large B cell lymphoma (R-R DLBCL)
-
2024-516373-77-00
5
2021-07-18
Adult cardiac arrest patients with sustained ROSC and hemodynamic fail
-
2023-510389-28-00
5
2021-06-14
short bowel syndrome
-
2022-500237-92-00
5
2021-04-23
Newly-diagnosed high-intermediate and high-risk diffuse large B-cell l
-
2023-507970-42-00
5
2021-03-31
PSMA-positive metastatic hormone-sensitive prostate cancer (mHSPC)
-
2023-507695-52-00
5
2021-03-05
Mantle cell lymphoma
-
2024-513325-23-00
4
2021-02-03
Myelofibrosis
-
2023-503384-41-00
5
2020-12-22
Relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
-
2022-501645-70-00
5
2020-11-25
Crohns Disease
-
2023-504828-25-00
9
2020-11-16
Chronic Lymphocytic Leukemia
-
2023-506877-37-00
5
2020-09-28
Relapsed/Refractory Multiple Myeloma
-
2022-502841-91-00
5
2020-08-12
Crohn’s Disease
-
2024-512269-14-00
5
2020-01-27
GIant cell Arteritis
-
2023-508635-31-00
5
2019-12-03
Hepatocellular Carcinoma
-
2023-504303-86-00
5
2019-11-21
High-risk hepatocellular carcinoma (HCC)
-
2024-510626-89-00
5
2019-11-18
Non-Alcoholic Steatohepatitis (NASH)
-
2023-509276-42-00
6
2019-10-30
Children and Adolescents with Cancers Harboring V600 mutation.
-
2024-513728-40-00
5
2019-07-02
scheduled surgery for digestive cancer
-
2024-516048-24-00
4
2019-06-19
CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE OR IN MYELOID BLAST
-
2024-516479-34-00
5
2019-05-17
Hepatocellular carcinoma
-
2023-509305-68-00
5
2019-05-16
Pulmonary arterial hypertension (PAH)